Atrás
Precio Nykode Therapeutics ASA (VACBF)
Gráfico del Precio de Acciones VACBF
VACBF Predicción del precio de las acciones
Nykode Therapeutics ASA
$0.38
22.58%
$0.07
Al cierre: Feb 12, 16:00:00 GMT-5
$0.38
0%
$0
Mercado Posterior: Feb 12, 16:53:57 GMT-5
Estadísticas clave
Cierre Anterior
$0.31
Precio de apertura
$0.38
Rango del día
$0.38 - $0.38
Rango de 52 semanas
$0.1557 - $0.38
Volumen
--
Volumen promedio
166
EPS (TTM)
-0.03
Rendimiento de dividendos
--
Cap. de mercado
$124.0M
¿Qué es NYKODE THERAPEUTICS ASA?
Nykode Therapeutics ASA is a clinical-stage biopharmaceutical company which engages in discovering and developing of novel immunotherapies. The company is headquartered in Oslo, Oslo and currently employs 62 full-time employees. The company went IPO on 2020-01-27. Nykode uses its vaccine technology platform to generate therapeutics in disease indications with unmet medical need. The firm develops next generation vaccines for clinical use, based on a deep understanding of immunological principles. Nykode Therapeutics’ main product candidates are VB10.16 and VB10.NEO. VB10.16 is a therapeutic cancer vaccine against HPV16-related cancers. VB10. NEO is a therapeutic cancer neoantigen vaccine. The firm also has two universal COVID-19 vaccine candidates in development.
Características
© 2026 Finture Development Limited. Todos los derechos reservados.